» Factor XII Deficient Plasma Native

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED CONGENITAL DEFICIENT PLASMAS INTRINSIC PATHWAY

Factor XII Deficient Plasma Native

Lyophilized plasmas

Plasma deficient for Factor XII assay.

Native Factor XII Deficient Plasma is a pool of donor plasmas deficient in FXII, native (congenital deficiency), lyophilized, with a coagulant activity <3% for FXII.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5194008
Presentation	Vial
Format	5 x 1.0 mL
Number of assays	100
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Number of assays	Quote	Product sheet
4-5194008	Vial	5 x 1.0 mL	100

Price list, safety data sheets and notices are accessible to our registered customers.

Factor XII (FXII) is a glycoprotein synthesized by the liver. FXII participates in the contact phase which initiates the intrinsic pathway of coagulation.
Activated on contact with a negatively charged surface, it becomes capable of activating prekallikrein and kallikrein (amplified by KHPM) then FXI to FXIa in the presence of KHPM.
The FXIa thus formed activates the FXII in FXIIa, amplifying the reaction.

- Deficient human plasma, stabilized and lyophilized with an activity <3% of the corresponding coagulation factor.
- All other coagulation factors have normal values.
- Native FXII deficient plasma is used for the determination of FXII by a one-step method based on Activated Cephalin Time (TCA).

- 5 vials x 1 mL lyophilized plasma

Coagulation Control A
Coagulation Control N
Coagulation Reference

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED CONGENITAL DEFICIENT PLASMAS INTRINSIC PATHWAY

Factor XII Deficient Plasma Native

Lyophilized plasmas

Price list, safety data sheets and notices are accessible to our registered customers.

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep Catalogue
Thrombosis Haemostasis 2023

Cryopep Catalogue
Haemostasis Research 2023

Cryopep LYOPHILIZED CONGENITAL DEFICIENT PLASMAS

Product sheet Factor XII Deficient Plasma Native

You must identify yourself to search for a certificate of analysis

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED CONGENITAL DEFICIENT PLASMAS INTRINSIC PATHWAY

Factor XII Deficient Plasma Native

Lyophilized plasmas

Product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

Price list, safety data sheets and notices are accessible to our registered customers.